New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease

Medical researchers have found that adding a simple molecular chain to a standard medication for lung disease creates a new therapy that shows promise for difficult-to-treat cases resulting from acute lung injury. Scientists from the University of California San Francisco led the team, which also included researchers from the University of Rochester and the Karolinska Institute in Sweden.

The standard medication is artificial surfactant, a detergent-like liquid that is administered directly into the lungs. Studies in animal models showed the extra molecular chain--made of a compound bio-compatible with mammalian tissue--appears to act as a protective barrier, allowing normal function of a key substance that lines the air spaces in the lungs. This substance is natural surfactant, a lung secretion that is vital to normal pulmonary function because it keeps the lungs from collapsing after each breath.

Reporting today (May 4) at the annual meeting of the Pediatric Academic Societies in San Francisco, principal investigator H. William Taeusch, MD, of UCSF, said rats with diseased lungs treated with the enhanced medication had improved oxygen levels in the blood, an indication that lung function is not compromised.

"The study findings are dramatic, and we are excited at the potential of someday successfully treating infants and adults who have lung problems that don't respond well to current treatment. We have been frustrated with the poor outcome in these groups, and our results suggest that we could be on the road to a much-improved therapy," said Taeusch, who is a UCSF professor of pediatrics and chief of the Department of Pediatrics at the UCSF-affiliated San Francisco General Hospital Medical Center.

Some 5,000-10,000 infants and 100,000 adults in the U.S. suffer from acute lung injury every year. Their disease differs from premature babies who at birth suffer from respiratory distress syndrome--also known as hyaline membrane disease-

Contact: Corinna Kaarlela
University of California - San Francisco

Page: 1 2 3

Related medicine news :

1. Artificial liver trials show progress, as transplant candidates wait
2. Artificial organs
3. Artificial liver moves toward commercialization
4. Trial Begins For First Artificial Liver Device Using Human Cells
5. Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction
6. Research Shows That Noncompliance Is Responsible For Half The Cases Of Nonresponse To Antihypertensive Drug Treatment
7. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
8. Anti-Depressant Drug Shows Promise As Weight-Loss Treatment
9. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
10. Evidence Shows Drug-Psychotherapy Combo Effective For Chronic Depression
11. Research Shows Religion Plays A Major Role In Health, Longevity

Post Your Comments:

(Date:8/17/2018)... , ... August 17, 2018 , ... ... today announced that it is introducing its new MedAttentive Solution at the ... offerings by delivering customized alerts and notices that follow patients through all points ...
(Date:8/17/2018)... ... August 17, 2018 , ... Inc. magazine today ... most prestigious ranking of the nation’s fastest-growing private companies. The list represents a ... segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, ...
(Date:8/17/2018)... ... August 17, 2018 , ... Charles E. Crutchfield III, ... patient, Haps, a sand tiger shark, to help with his scoliosis (abnormal curvature of ... well as in human care, can develop scoliosis. Some types of scoliosis are caused ...
(Date:8/15/2018)... ... August 15, 2018 , ... Today David Hyde Apparel ... , Born out of a desire for confidence and comfort year-round, the ... body odor – even in the hottest, most humid of climates. , The brainchild ...
(Date:8/15/2018)... ... August 15, 2018 , ... ... Psy.D., BCBA-D, to associate editor of Behavior Analysis in Practice, one of the ... the chief clinical standards and research officer for Trumpet, leading the company’s research ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... Pa. (PRWEB) , ... August 15, 2018 , ... ... Health officials today broke ground on a new full-service hospital in Pine ... to the residents of Pittsburgh’s northern suburbs. , Expected to open ...
(Date:8/15/2018)... ... , ... Help Your Diabetes (HYD) is a Patent Pending, Internationally known, Natural, ... their medication, working in conjunction with their primary physician. , The Founder/CEO, Dr. ... of "Imagine Living Without Type 2 Diabetes. Dr. Hockings has given over 240 diabetes ...
(Date:8/15/2018)... RAPIDS, Mich. (PRWEB) , ... August 15, 2018 ... ... an addition to their expansive lineup of casters. The newly designed Diamond ... of movement and stability. Manufactured with an antimicrobial compound injected into a ...
Breaking Medicine Technology:
Cached News: